Entries from 2026-01-01 to 1 month

NSCLC臨床試験分析:10社以上の企業と治療法による強力なパイプラインに関する重要な洞察 | DelveInsight

DelveInsightの「非小細胞肺がんパイプライン・インサイト2025」レポートは、10社以上の企業と10以上の新規治療法に焦点を当て、NSCLCパイプラインの詳細な分析を提供しています。本レポートは、臨床段階および前臨床段階におけるNSCLCパイプライン薬の詳細…

7MMの腎臓移植拒絶反応治療薬市場規模は2034年までにかなりのCAGRで成長すると予測、DelveInsight

DelveInsight の「腎臓移植拒絶反応市場の洞察、疫学、市場予測 – 2034 年」レポートでは、過去および将来の疫学、米国、EU4 (ドイツ、フランス、イタリア、スペイン)、英国、日本の治療薬市場の動向など、腎臓移植拒絶反応に関する詳細な理解が得られます。…

DelveInsightの推定によると、7MMの妊娠中毒症治療薬市場は2024年に約8,000万米ドルに達し、2034年までに拡大すると予測されています。

DelveInsightの「妊娠中毒症市場の洞察、疫学、市場予測 - 2034年」レポートは、妊娠中毒症の疫学、市場動向、そして臨床的進歩に関する包括的なレビューを提供しています。本レポートには、過去および予測の疫学データと市場データに加え、米国、EU4(ドイ…

多系統萎縮症のパイプラインは力強い勢いを示し、20社以上の主要製薬企業が治療薬開発を牽引 | DelveInsight

DelveInsightの最新レポート「多系統萎縮症パイプラインの洞察、2025年」は、多系統萎縮症(MSA)のパイプラインを詳細に分析し、20社以上の企業と22種類以上のパイプライン医薬品を取り上げています。本レポートでは、臨床段階と非臨床段階を横断したMSAパ…

Artificial Cornea and Corneal Implant Market Analysis: Innovation, Competition, and Growth Outlook

Modern ophthalmology is experiencing a transformative shift as breakthrough technologies address the pressing challenge of corneal blindness and vision impairment. Though conventional corneal transplantation has historically been the go-to…

Market Forecast and Disease Trends for Dermatophagoides farinae–Linked Allergic Asthma

In bedrooms and living spaces around the world, an invisible adversary lurks within the fabric of everyday life. Dermatophagoides farinae, commonly known as the American house dust mite, stands as a formidable trigger for allergic asthma, …

JAK Inhibitors Driving a New Era in Targeted Immune Therapies

The pharmaceutical industry stands at a pivotal juncture as JAK inhibitors reshape therapeutic strategies for autoimmune and inflammatory disorders. This innovative class of medications has captured the attention of clinicians, researchers…

Automated Suturing Devices Industry Overview with Forecast to 2030

Modern surgical practices are undergoing a dramatic transformation as cutting-edge technologies reshape traditional operating room procedures. Among these groundbreaking innovations, Automated Suturing Devices stand out as game-changers th…

DelveInsightによると、7MMにおけるチミジンキナーゼ2欠損症の市場規模は2023年に約100万米ドルに達し、2034年まで安定したCAGRで成長すると予測されています。

DelveInsightのレポート「チミジンキナーゼ2欠損症市場の洞察、疫学、市場予測 - 2034年」は、チミジンキナーゼ2欠損症の疫学、市場動向、そして臨床的進歩に関する包括的な分析を提供しています。また、過去および予測の疫学データと市場データに加え、米国…

Growth Factors Influencing the Campylobacter Infections Market

Campylobacter infections remain a formidable public health concern, affecting countless individuals across the globe each year. As one of the leading bacterial causes of foodborne illness, these infections demand urgent attention from heal…

Global Demand and Innovation Trends in the Scleritis Market

Scleritis represents a challenging inflammatory condition affecting the sclera, the white outer protective coating of the eye. This painful and potentially vision-threatening disease has garnered increasing attention from ophthalmologists,…

Industry Landscape and Future Scope of the Dyspnea Market

Dyspnea, characterized by difficult or labored breathing, presents significant clinical and economic implications across global healthcare systems. This symptomatic manifestation occurs in diverse pathological conditions, creating complex …

Market Challenges and Innovations in Disseminated Intravascular Coagulation

Disseminated Intravascular Coagulation (DIC) stands as a critical medical emergency that demands immediate attention and sophisticated treatment approaches. This complex hematological disorder, marked by widespread activation of the clotti…

Urinary Catheters Market Trends: Technology, Usage, and Adoption

Healthcare technology advancement remains a cornerstone of modern medical practice, with urinary catheters serving as essential instruments in patient management across diverse care settings—from acute hospital environments to home-based c…

DelveInsight Evaluation of Marfan Syndrome Market Opportunities

Marfan syndrome is an inherited genetic condition that disrupts the body's connective tissue due to mutations in the FBN1 gene, which is responsible for producing fibrillin-1 protein. This disorder can affect various systems throughout the…

Emerging Therapies and Market Forces in Cryoglobulinemia Care

Cryoglobulinemia is a relatively obscure medical condition characterized by abnormal immunoglobulins that precipitate when exposed to lower temperatures. Recent developments in pharmaceutical research and clinical understanding are driving…

Basal Cell Nevus Syndrome Therapeutics Landscape and Market Forecast

Basal Cell Nevus Syndrome (BCNS), alternatively known as Gorlin Syndrome, stands as a rare genetic condition distinguished by recurring basal cell carcinomas, jawbone cysts, skeletal deformities, and additional systemic manifestations. Thi…

New Directions in Panic Disorder Diagnosis and Treatment

Panic disorder represents a significant psychiatric condition affecting approximately 2-3% of the global population, characterized by recurrent, unexpected panic attacks and persistent concerns about future episodes. The condition poses su…

Abetalipoproteinemia Market Developments and Unmet Medical Needs

Living with abetalipoproteinemia, sometimes called Bassen-Kornzweig syndrome, means navigating a complex journey that begins in early childhood. This rare genetic condition disrupts the body's ability to process fats and absorb essential v…

Innovation and Investment Trends in the OX40 Ligand Inhibitors Market

There's something genuinely exciting happening in the world of immunotherapy right now. OX40 ligand inhibitors are emerging as a sophisticated new weapon against autoimmune and inflammatory diseases, and they're doing it in a way that's sm…

How Fucosidosis Develops and Why It Matters

Fucosidosis represents an exceptionally uncommon inherited metabolic condition that poses significant diagnostic and therapeutic challenges. This lysosomal storage disease arises from deficient alpha-L-fucosidase enzyme activity, resulting…